Environmental Controls & Personal Protection to Reduce the Risk of Infection In addition to administrative controls, environment controls and personal protection [32] are also essential in reducing ...

Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and ...

Breast tuberculosis, a rare form of extrapulmonary tuberculosis, represents a diagnostic challenge due to its nonspecific clinical and imaging features that can mimic both benign and malignant breast ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

Tuberculosis is most common during a woman's reproductive years and is a major cause of maternal-child mortality. National guidelines for screening and management vary widely owing to insufficient ...

The American Thoracic Society (ATS), the U.S. Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of American (IDSA) announce the release of the first completely ...

In a recent study published in the journal Clinical Infectious Diseases, researchers reported on the treatment of rifampin-resistant tuberculosis in the United States (U.S.) using the Food and Drug ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

“Is it just happening to me or is it experienced by everyone who once battled TB?” “Am I being heard?” “When will this end?” “Will this ever end?” “Why me?” “What’s the point of going through so much ...

A significant proportion of people in the community with pulmonary tuberculosis (TB) have subclinical disease, according to a meta-analysis involving survey studies across Africa and Asia. In adjusted ...

Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first ...